These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10150613)

  • 1. Score one for drug screeners.
    Uehling M
    CAP Today; 1995 Jun; 9(6):1, 10-14. PubMed ID: 10150613
    [No Abstract]   [Full Text] [Related]  

  • 2. Industrial employee drug screening: a blind study of laboratory performance using commercially prepared controls.
    Knight SJ; Freedman T; Puskas A; Martel PA; O'Donnell CM
    J Occup Med; 1990 Aug; 32(8):715-21. PubMed ID: 2401928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accreditation should be discussed! Need for substance abuse testing at the workplace should be increased].
    Beck O; Hjemdahl P
    Lakartidningen; 1998 Jan; 95(5):407-8. PubMed ID: 9492489
    [No Abstract]   [Full Text] [Related]  

  • 4. A guide to NIDA certification for workplace drug testing.
    Armbruster DA
    MLO Med Lab Obs; 1992 Feb; 24(2):31-2, 34, 36. PubMed ID: 10171052
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saving laboratory records: what, how, how long?
    Baer D
    MLO Med Lab Obs; 2004 May; 36(5):10-1, 14-6; quiz 18-20. PubMed ID: 15179913
    [No Abstract]   [Full Text] [Related]  

  • 7. Proficiency testing of drug analysis laboratories.
    McCoy HG
    J Occup Med; 1991 Apr; 33(4):422, 429-30. PubMed ID: 1645401
    [No Abstract]   [Full Text] [Related]  

  • 8. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finnish guidelines for workplace drug testing.
    Lillsunde P; Haavanlammi K; Partinen R; Mukala K; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):99-102. PubMed ID: 17499950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing a drug test panel: concepts and considerations.
    Sagall R
    Occup Health Saf; 2005 Apr; 74(4):83-5. PubMed ID: 15915700
    [No Abstract]   [Full Text] [Related]  

  • 11. [Creatinine concentration in urine should be measured in drug testing. Guidelines for decision limits and interpretation are necessary--at any rate for legal rights].
    Helander A; Ohlson M; Beck O; Hansson T; Kugelberg FC; Kronstrand R
    Lakartidningen; 2011 Jun 15-28; 108(24-25):1311-4. PubMed ID: 21830503
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the results of a three-year program for National Standardization and Quality Improvement of Medical Laboratories on Drug of Abuse Testing by the Ministry of Health in Turkey.
    Küme T; Mercan F; Topsakal H; Karakukcu C; Şeneş M; Pınar A; Gürler M; Kalafat H; Ünal B; Verstraete AG; Hamurtekin Y; Aydınlı A; Şenol Y; Eğin ME; Cihan A; Kazancı EG; Gümüş E
    Drug Test Anal; 2019 Feb; 11(2):215-222. PubMed ID: 30107637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
    Lippi G; Franchini M; Guidi G
    Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Internal quality control : false-rejections and preliminary period].
    Marquis P
    Ann Biol Clin (Paris); 2001; 59(2):214-8. PubMed ID: 11282527
    [No Abstract]   [Full Text] [Related]  

  • 16. ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007.
    Ventura M; Ventura R; Pichini S; Leal S; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Nov; 182(1-3):35-40. PubMed ID: 19004584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1990 Sep; 55(172):36317-8. PubMed ID: 10170592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 19. SUBPART F--drug testing laboratories.
    Occup Health Saf; 2000 Apr; 69(4):40-6, 109. PubMed ID: 11396026
    [No Abstract]   [Full Text] [Related]  

  • 20. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1991 Jan; 56(1):77-8. PubMed ID: 10128596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.